Deborah E. Citrin

Deborah E. Citrin is a renowned oncologist and radiation therapist based in the United States. She is currently serving as a Senior Investigator at the Radiation Oncology Branch of the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH). Her research primarily focuses on the development of novel therapeutic strategies to enhance the efficacy of radiation therapy and improve the outcomes for cancer patients.

Early Life and Education

Deborah E. Citrin completed her undergraduate studies at the University of Pennsylvania, where she majored in Biology. She then pursued her medical degree from the University of Medicine and Dentistry of New Jersey. Following her graduation, she completed her residency in Radiation Oncology at the National Cancer Institute.

Career

Citrin began her career at the National Cancer Institute where she has made significant contributions to the field of oncology. Her research has been instrumental in understanding the role of radiation therapy in cancer treatment. She has also been involved in numerous clinical trials aimed at improving the efficacy of radiation therapy.

Research

Citrin's research primarily focuses on the development of novel therapeutic strategies to enhance the efficacy of radiation therapy. She has conducted extensive research on the role of immune response in radiation therapy and has published numerous papers on the subject. Her work has significantly contributed to the understanding of the complex interactions between the immune system and radiation therapy.

Publications

Citrin has authored and co-authored numerous scientific publications in the field of oncology and radiation therapy. Her work has been published in several prestigious medical journals, including the Journal of Clinical Oncology and the International Journal of Radiation Oncology.

Awards and Recognition

In recognition of her contributions to the field of oncology, Citrin has received several awards and honors. These include the National Institutes of Health Merit Award and the American Society for Radiation Oncology (ASTRO) Gold Medal.

‎